EGFR Amplification in Metastatic Colorectal Cancer.
Giovanni RandonRona YaegerJaclyn F HechtmanFrancesco PantanoGiovanni FucàHenry WalchJeeyun LeeElena ÉlezJenny SeligmannBenedetta MussolinFilippo PaganiMarco Maria GermaniMargherita AmbrosiniDaniele RossiniMargherita RattiFrancesc SalvàSusan D RichmanHenry M WoodGouri NanjangudAnnunziata GloghiniMassimo MilioneAlberto BardelliFilippo G De BraudFederica MoranoChiara CremoliniFilippo PietrantonioPublished in: Journal of the National Cancer Institute (2022)
Patients with EGFR-amplified mCRC represent a biologically defined subgroup and merit dedicated clinical trials with novel and more potent EGFR-targeting strategies beyond single-agent monoclonal antibodies.